Orange Book product · Generic (ANDA)
HYDROCORTISONE
HYDROCORTISONE
At a glance
Aug 20, 2010
Approved
Generic (ANDA)
Application
AT
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 20, 2010
16 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
HYDROCORTISONE
Strength
2.5%
Dosage form
CREAM
Route
TOPICAL
TE code
AT
Application
ANDA 040879
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of HYDROCORTISONE
- —CORT-DOMEBrand (NDA)
NDA 009585 · BAYER PHARMS
- 2018HYDROCORTISONEGeneric (ANDA)
ANDA 203810 · ENCUBE
- 2016ALA-CORTGeneric (ANDA)
ANDA 080706 · CROWN LABS
- 2004HYDROCORTISONEGeneric (ANDA)
ANDA 040503 · CHARTWELL MOLECULAR
- 1989HYDROCORTISONEGeneric (ANDA)
ANDA 089273 · TOPIDERM
- 1989HYDROCORTISONEGeneric (ANDA)
ANDA 089754 · ALPHARMA US PHARMS
- 1988NOGENIC HCGeneric (ANDA)
ANDA 087427 · IVAX PHARMS
- 1988HYDROCORTISONEGeneric (ANDA)
ANDA 089682 · ACTAVIS MID ATLANTIC
- 1988HYDROCORTISONEGeneric (ANDA)
ANDA 089706 · NASKA
- 1986HYDROCORTISONEGeneric (ANDA)
ANDA 089414 · FOUGERA PHARMS INC
- 1986HYDROCORTISONEGeneric (ANDA)
ANDA 089413 · PHARMADERM
- 1986HYDROCORTISONEGeneric (ANDA)
ANDA 088845 · PHARMADERM
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
